The two-day tour of Shaoguan for all employees has concluded successfully!

Taking a temporary break from demanding work and escaping the hustle and bustle of the city, participants admired the graceful beauty of lotus flowers and savored authentic farmhouse cuisine. In recognition of the hard work and dedication of all company employees, and to foster better communication and collaboration among staff while strengthening team building, on July 14, 2018, Deer Company organized a two-day “A Date with Nature—Shaoguan Excursion” for more than 200 employees.

2018

Dier Bio’s 2018 Mid-Year Performance Review and Evaluation Conference Concludes Successfully

On the afternoon of July 9, 2018, the three-day 2018 Mid-Year Performance Review and Evaluation Conference of Zhuhai Deer Bioengineering Co., Ltd. was solemnly held in the Training Room of Building No. 3 at the Deer Bio Park. Chairman Lin Huaqing, heads of all centers and departments, and members of the marketing team—totaling 55 participants—attended the meeting.

2018

Regulations on Biosafety Management of Pathogenic Microorganism Laboratories

(Promulgated by Order No. 424 of the State Council of the People’s Republic of China on November 12, 2004; amended in accordance with the Decision of the State Council on Amending Certain Administrative Regulations dated February 6, 2016; further revised pursuant to the Decision of the State Council on Amending and Repealing Certain Administrative Regulations dated March 19, 2018) Chapter I General Provisions Article 1 This Regulation is enacted to strengthen biosafety management of pathogenic microorganism laboratories (hereinafter referred to as “laboratories”), and to protect the health of laboratory personnel and the general public. Article 2 The provisions of this Regulation shall apply to laboratories within the territory of the People’s Republic of China and to the biosafety management of their experimental activities.

2018

The first Employee Labor Skills Competition of Deer Biotechnology has concluded successfully.

In the golden autumn of August, with clear skies and crisp air, after a month of planning and preparation, Zhuhai Deer Bioengineering Co., Ltd. held its first-ever employee labor skills competition on August 16, 2018—

2018

Measures for the Management of Hospital-Acquired Infections

Ministry of Health Order No. 48: The Measures for the Management of Hospital‑Acquired Infections was deliberated and adopted at the Ministry of Health’s Executive Meeting on June 15, 2006, and is hereby promulgated, entering into force on September 1, 2006. Minister Gao Qiang July 6, 2006 Measures for the Management of Hospital‑Acquired Infections Chapter I General Provisions Article 1 In order to strengthen the management of hospital‑acquired infections, effectively prevent and control such infections, improve the quality of medical care, and ensure medical safety, these Measures are formulated in accordance with the provisions of the Law on the Prevention and Control of Infectious Diseases, the Regulations on the Administration of Medical Institutions, the Regulations on Emergency Response to Public Health Emergencies, and other relevant laws and administrative regulations. Article 2 Medical…

2018

2018 Autumn CMEF Exhibition: A Highlight Reel of Dier Biotech

As a comprehensive industry service platform in the Asia-Pacific region that covers the entire medical device value chain—integrating product technology, service innovation, trade, academic exchange, and education—the current exhibition is themed “CMEFgoForward,” inviting industry partners to jointly witness the progress of China’s medical device sector. Dier Bio has increased its R&D investment, leveraging innovation to drive industrial upgrading, and showcased at this event a suite of automated instruments and accompanying reagents for infectious disease diagnostics—including bacterial morphology analysis, bacterial culture, identification, and in vitro antimicrobial susceptibility testing—all developed in-house. Notably, the D2Mini bacterial identification and antimicrobial susceptibility testing system excels in interpretation…

2018

< 1...18 19 20...33 >

DL Biotech: Making infectious disease diagnosis faster and more accurate.

Are you ready to embark on a journey into the world of microbes?

DL Biotech WeChat Official Account

Tel: 0756-3391888

Zhuhai DL Biotech Co., Ltd.
Address: No. 59, Dingwan 10th Road, Jinwan District, Zhuhai City
Email: market@medicaldl.com
dl@medicaldl.com (for export business)
National After-Sales Customer Service Hotline: 400-9313-018
International Customer Service Hotline: +86 756 6292044

Consult Now

SEO tags

Business license

market@medicaldl.com：market@medicaldl.com

86-756-6293238：86-756-6293238

Sorry, there is currently no content in this section.

You can view other sections.

Sorry, there is currently no content in the current column

You can check other sections

Business license

Business License